Cargando…
Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
Introduction: Despite intensive research, reliable blood-derived parameters to detect clinically significant portal hypertension (CSPH) in patients with cirrhosis are lacking. As altered homeostasis of cyclic guanosine monophosphate (cGMP), the central mediator of vasodilatation, is an essential fac...
Autores principales: | Sturm, Lukas, Bettinger, Dominik, Roth, Lisa, Zoldan, Katharina, Stolz, Laura, Gahm, Chiara, Huber, Jan Patrick, Reincke, Marlene, Kaeser, Rafael, Boettler, Tobias, Kreisel, Wolfgang, Thimme, Robert, Schultheiss, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764357/ https://www.ncbi.nlm.nih.gov/pubmed/35059421 http://dx.doi.org/10.3389/fmed.2021.803119 |
Ejemplares similares
-
Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension
por: Sturm, Lukas, et al.
Publicado: (2023) -
Proton pump inhibitor treatment is associated with acute-on-chronic liver failure in patients with advanced cirrhosis
por: Sturm, Lukas, et al.
Publicado: (2023) -
Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension
por: Schaffner, Denise, et al.
Publicado: (2018) -
Monovalent selectivity of the cyclic guanosine monophosphate-activated ion channel
Publicado: (1990) -
Regulation of Biofilm Exopolysaccharide Production by Cyclic Di-Guanosine Monophosphate
por: Poulin, Myles B., et al.
Publicado: (2021)